The Proteomics Shared Resource is a new Cancer Center SR that evolved from an established facility at CUMC with strong expertise in all aspects of sample preparation and mass spectrometric analysis that will be increasingly applied to cancer related research projects. The goal is to provide an essential battery of mass spectrometry-based proteomics tools to HICCC investigators. Specific services are to use state-ofthe- art experimental strategies for: ? Identification of proteins by in-gel digestion and mass spectrometry ? Identification of protein components within protein complexes ? Identification of phosphorylation sites and other covalent protein modifications Instrumentation in this facility includes two high-resolution quadrupole-TOF electrospray mass spectrometers equipped with nanoflow LC for LC-MS, and a MALDI-TOF mass spectrometer. A key activity will be education of researchers in the ways state-of-the-art proteomics tools can advance their research. The HICCC has made recent investments in the facility infrastructure, and has been publicizing the facility to HICCC members, leading to an increased focus on mass spectrometry for cancer research. However, currently the facility has minimal financial support for daily operating expenses from the HICCC and has raised funds for its continued operation by offering cost-effective mass spectrometry services to outside investigators. In this grant renewal we are proposing increased direct support for this Shared Resource. The facility will continue to have close intervhactions with investigators, advising them on experimental design, sample preparation, and data interpretation. Future goals include the implementation of quantitative proteomics techniques based on labeling methods coupled with LC-MS, and the expansion of the Resource to include a two-dimensional gel electrophoresis service. Gel-based proteomics will facilitate investigation of protein mixtures of greater complexity such as those found in tissues and biological fluids, and opens the possibility of finding novel diagnostic markers and therapeutic targets. During the last period of the CCSG (transitioning to Cancer Center management) 34% of the Columbia investigators using the facility were Center members with peer-reviewed funding, with those members representing over 30% of the utilization of the services. The proposed total operating budget of the facility is $380,006, of which we are requesting $84,858 from CCSG.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
New York
United States
Zip Code
Jauregui, Ruben; Park, Karen Sophia; Duong, Jimmy K et al. (2018) Quantitative progression of retinitis pigmentosa by optical coherence tomography angiography. Sci Rep 8:13130
O'Neil, Daniel S; Prigerson, Holly G; Mmoledi, Keletso et al. (2018) Informal Caregiver Challenges for Advanced Cancer Patients During End-of-Life Care in Johannesburg, South Africa and Distinctions Based on Place of Death. J Pain Symptom Manage 56:98-106
Liu, Katherine Y; Sengillo, Jesse D; Velez, Gabriel et al. (2018) Missense mutation in SLIT2 associated with congenital myopia, anisometropia, connective tissue abnormalities, and obesity. Orphanet J Rare Dis 13:138
Koch, Susanne F; Tsang, Stephen H (2018) Success of Gene Therapy in Late-Stage Treatment. Adv Exp Med Biol 1074:101-107
DiCarlo, James E; Mahajan, Vinit B; Tsang, Stephen H (2018) Gene therapy and genome surgery in the retina. J Clin Invest 128:2177-2188
Wert, Katherine J; Velez, Gabriel; Cross, Madeline R et al. (2018) Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface. Free Radic Biol Med 124:408-419
Schrank, Benjamin R; Aparicio, Tomas; Li, Yinyin et al. (2018) Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559:61-66
Lee, Andreia; CingĂ–z, Oya; Sabo, Yosef et al. (2018) Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus. Virology 516:165-175
Hernandez, Celine; Huebener, Peter; Pradere, Jean-Philippe et al. (2018) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest 128:2436-2451
Proto, Jonathan D; Doran, Amanda C; Gusarova, Galina et al. (2018) Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 49:666-677.e6

Showing the most recent 10 out of 331 publications